Science watch

Our science watch section reports on the story behind the media-reported “breakthrough” headlines in dementia, by focusing on the original journal study. Reports of other developments in research on care and cure are also included.

13/03/2019		Scientists investigate links between extended family history and relative risk of developing AD
04/03/2019		Observational study assesses relationship between type 2 Diabetes treatment status and AD-related outcomes
28/02/2019		Researchers investigate association between antiepileptic drug use and risk of dementia
20/02/2019		The University of Dundee Drug Discovery Unit announces partnership with Takeda to develop new treatments for tau pathology
18/02/2019		Alzheimer’s Research UK funds Phase II clinical trial for agitation in AD
18/02/2019		Study finds ethnoracial differences in AD
13/02/2019		GeneMatch program reports on feasibility of online recruitment registry for AD research
11/02/2019		Scientists aim to understand reasons for reduced blood flow and subsequent cognitive impairment in AD
07/02/2019		Recent study reports that a hormone produced during exercise might protect against AD
06/02/2019		Study reports a link between mid-life inflammation and cognitive decline in old age
04/02/2019		Researchers investigate sex differences in Alzheimer’s disease
04/02/2019		Scientists publish findings on region-specific brain changes in AD
30/01/2019		Roche halts its Phase III CREAD1 and CREAD2 studies of AD drug crenezumab
28/01/2019		SPRINT MIND study reports on results and Alzheimer's Association grants funding of over USD 800,000 to launch extended 2.0 study
28/01/2019		Researchers investigate association between antiepileptic drug use and risk of dementia

 

Next » 1 2 3 4 5 ...107